Format
Sort by

Send to

Choose Destination

Links from Protein

Items: 1 to 20 of 128

1.

A single-nucleotide polymorphism of CCL21 rs951005 T>C is associated with susceptibility of polymyositis and such patients with interstitial lung disease in a Chinese Han population.

Chen S, Wang Q, Wu CY, Wu QJ, Li Y, Wu ZY, Li P, Sun F, Zheng WJ, Deng CW, Zhang FC, Li YZ.

Clin Exp Rheumatol. 2015 Sep-Oct;33(5):639-46. Epub 2015 Aug 31.

PMID:
26320593
2.

[Over-expression of CCL21 up-regulates the antigen presentation-related genes of CK8/18 positive thymic epithelial cells in patients with myasthenia gravis].

Zhang Y, Zhao J, Zhu Z, Yin T, Xuan X, Liu P, Li Q, DU Y.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jul;31(7):957-60. Chinese.

PMID:
26146068
3.

TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis.

Pang MF, Georgoudaki AM, Lambut L, Johansson J, Tabor V, Hagikura K, Jin Y, Jansson M, Alexander JS, Nelson CM, Jakobsson L, Betsholtz C, Sund M, Karlsson MC, Fuxe J.

Oncogene. 2016 Feb 11;35(6):748-60. doi: 10.1038/onc.2015.133. Epub 2015 May 11.

4.

Central Nervous System and Peripheral Expression of CCL19, CCL21 and Their Receptor CCR7 in Experimental Model of Multiple Sclerosis.

Bielecki B, Jatczak-Pawlik I, Wolinski P, Bednarek A, Glabinski A.

Arch Immunol Ther Exp (Warsz). 2015 Oct;63(5):367-76. doi: 10.1007/s00005-015-0339-9. Epub 2015 May 10.

5.

The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.

Tutunea-Fatan E, Majumder M, Xin X, Lala PK.

Mol Cancer. 2015 Feb 10;14:35. doi: 10.1186/s12943-015-0306-4.

6.

The HIV-1 Gp120/CXCR4 axis promotes CCR7 ligand-dependent CD4 T cell migration: CCR7 homo- and CCR7/CXCR4 hetero-oligomer formation as a possible mechanism for up-regulation of functional CCR7.

Hayasaka H, Kobayashi D, Yoshimura H, Nakayama EE, Shioda T, Miyasaka M.

PLoS One. 2015 Feb 17;10(2):e0117454. doi: 10.1371/journal.pone.0117454. eCollection 2015.

7.

[CCL21 promotes the metastasis of human pancreatic cancer Panc-1 cells via epithelial- mesenchymal transition].

Liu Q, Chen F, Duan T, Zhu H, Xie X, Wu Y, Zhang Z, Wang D.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2015 Jan;31(1):6-9, 13. Chinese.

PMID:
25575049
8.

Slug signaling is up-regulated by CCL21/CCR7 [corrected] to induce EMT in human chondrosarcoma.

Li G, Yang Y, Xu S, Ma L, He M, Zhang Z.

Med Oncol. 2015 Feb;32(2):478. doi: 10.1007/s12032-014-0478-6. Epub 2015 Jan 3. Erratum in: Med Oncol. 2015 Mar;32(3):58.

PMID:
25556164
9.

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions.

Akhavanpoor M, Gleissner CA, Gorbatsch S, Doesch AO, Akhavanpoor H, Wangler S, Jahn F, Lasitschka F, Katus HA, Erbel C.

Drug Des Devel Ther. 2014 Nov 27;8:2359-71. doi: 10.2147/DDDT.S72394. eCollection 2014.

10.

The homeostatic chemokine CCL21 predicts mortality in aortic stenosis patients and modulates left ventricular remodeling.

Finsen AV, Ueland T, Sjaastad I, Ranheim T, Ahmed MS, Dahl CP, Askevold ET, Aakhus S, Husberg C, Fiane AE, Lipp M, Gullestad L, Christensen G, Aukrust P, Yndestad A.

PLoS One. 2014 Nov 14;9(11):e112172. doi: 10.1371/journal.pone.0112172. eCollection 2014.

11.

Increased CCL19 and CCL21 levels promote fibroblast ossification in ankylosing spondylitis hip ligament tissue.

Qin Y, He LD, Sheng ZJ, Yong MM, Sheng YS, Wei Dong X, Wen Wen T, Ming ZY.

BMC Musculoskelet Disord. 2014 Sep 26;15:316. doi: 10.1186/1471-2474-15-316.

12.

CCL21/CCR7 axis activating chemotaxis accompanied with epithelial-mesenchymal transition in human breast carcinoma.

Li F, Zou Z, Suo N, Zhang Z, Wan F, Zhong G, Qu Y, Ntaka KS, Tian H.

Med Oncol. 2014 Sep;31(9):180. doi: 10.1007/s12032-014-0180-8. Epub 2014 Aug 21.

PMID:
25142946
13.

Contribution of homeostatic chemokines CCL19 and CCL21 and their receptor CCR7 to coronary artery disease.

Cai W, Tao J, Zhang X, Tian X, Liu T, Feng X, Bai J, Yan C, Han Y.

Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1933-41. doi: 10.1161/ATVBAHA.113.303081. Epub 2014 Jul 2.

14.

Priming by chemokines restricts lateral mobility of the adhesion receptor LFA-1 and restores adhesion to ICAM-1 nano-aggregates on human mature dendritic cells.

Borgman KJ, van Zanten TS, Manzo C, Cabezón R, Cambi A, Benítez-Ribas D, Garcia-Parajo MF.

PLoS One. 2014 Jun 19;9(6):e99589. doi: 10.1371/journal.pone.0099589. eCollection 2014.

15.

Effect of secondary lymphoid tissue chemokine suppression on experimental ulcerative colitis in mice.

Zhang H, Zhang X, Ding X, Cao W, Qu L, Zhou G.

Genet Mol Res. 2014 Apr 29;13(2):3337-45. doi: 10.4238/2014.April.29.12.

16.

Increased number of Hassall's corpuscles in myasthenia gravis patients with thymic hyperplasia.

Matsui N, Ohigashi I, Tanaka K, Sakata M, Furukawa T, Nakagawa Y, Kondo K, Kitagawa T, Yamashita S, Nomura Y, Takahama Y, Kaji R.

J Neuroimmunol. 2014 Apr 15;269(1-2):56-61. doi: 10.1016/j.jneuroim.2014.01.011. Epub 2014 Jan 28.

PMID:
24556356
17.

Increased expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental Rickettsia conorii infection.

Astrup E, Ranheim T, Damås JK, Davì G, Santilli F, Jensenius M, Vitale G, Aukrust P, Olano JP, Otterdal K.

BMC Infect Dis. 2014 Feb 9;14:70. doi: 10.1186/1471-2334-14-70.

18.

Central role of interferon-beta in thymic events leading to myasthenia gravis.

Cufi P, Dragin N, Ruhlmann N, Weiss JM, Fadel E, Serraf A, Berrih-Aknin S, Le Panse R.

J Autoimmun. 2014 Aug;52:44-52. doi: 10.1016/j.jaut.2013.12.016. Epub 2014 Jan 3.

PMID:
24393484
19.

Genetics of rheumatoid arthritis contributes to biology and drug discovery.

Okada Y, Wu D, Trynka G, Raj T, Terao C, Ikari K, Kochi Y, Ohmura K, Suzuki A, Yoshida S, Graham RR, Manoharan A, Ortmann W, Bhangale T, Denny JC, Carroll RJ, Eyler AE, Greenberg JD, Kremer JM, Pappas DA, Jiang L, Yin J, Ye L, Su DF, Yang J, Xie G, Keystone E, Westra HJ, Esko T, Metspalu A, Zhou X, Gupta N, Mirel D, Stahl EA, Diogo D, Cui J, Liao K, Guo MH, Myouzen K, Kawaguchi T, Coenen MJ, van Riel PL, van de Laar MA, Guchelaar HJ, Huizinga TW, Dieudé P, Mariette X, Bridges SL Jr, Zhernakova A, Toes RE, Tak PP, Miceli-Richard C, Bang SY, Lee HS, Martin J, Gonzalez-Gay MA, Rodriguez-Rodriguez L, Rantapää-Dahlqvist S, Arlestig L, Choi HK, Kamatani Y, Galan P, Lathrop M; RACI consortium; GARNET consortium, Eyre S, Bowes J, Barton A, de Vries N, Moreland LW, Criswell LA, Karlson EW, Taniguchi A, Yamada R, Kubo M, Liu JS, Bae SC, Worthington J, Padyukov L, Klareskog L, Gregersen PK, Raychaudhuri S, Stranger BE, De Jager PL, Franke L, Visscher PM, Brown MA, Yamanaka H, Mimori T, Takahashi A, Xu H, Behrens TW, Siminovitch KA, Momohara S, Matsuda F, Yamamoto K, Plenge RM.

Nature. 2014 Feb 20;506(7488):376-81. doi: 10.1038/nature12873. Epub 2013 Dec 25.

20.

The lymphoid chemokine CCL21 enhances the cytotoxic T lymphocyte-inducing functions of dendritic cells.

Hong CY, Lee HJ, Kim HJ, Lee JJ.

Scand J Immunol. 2014 Mar;79(3):173-80. doi: 10.1111/sji.12145.

Items per page

Supplemental Content

Write to the Help Desk